Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.46 |
| ▸ | POLB | P06746 | 5/20 | 0.46 |
| ▸ | HPGD | P15428 | 4/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3476583 | 0.89 | L3MBTL1 (0.52) | L3MBTL1ALDH1A1PKMKDM4EPOLB | |
| SCHEMBL17595049 | 0.89 | L3MBTL1 (0.59) | L3MBTL1ALDH1A1PKMKDM4EPOLB | |
| SCHEMBL19194844 | 0.84 | L3MBTL1 (0.54) | L3MBTL1ALDH1A1PKMKDM4EPOLB | |
| SCHEMBL6045136 | 0.82 | L3MBTL1 (0.47) | L3MBTL1ALDH1A1PKMKDM4EPOLB | |
| SCHEMBL14720808 | 0.82 | L3MBTL1 (0.41) | L3MBTL1ALDH1A1PKMKDM4EPOLB | |
| SCHEMBL3477651 | 0.81 | ALDH1A1 (0.48) | ALDH1A1PKMKDM4EPOLBHPGD | |
| SCHEMBL13132170 | 0.80 | CYP1A2 (0.40) | ALDH1A1PKMKDM4EPOLBHPGD | |
| SCHEMBL3016916 | 0.79 | CYP1A2 (0.36) | L3MBTL1ALDH1A1KDM4EPOLBHPGD | |
| SCHEMBL3477637 | 0.76 | L3MBTL1 (0.50) | L3MBTL1ALDH1A1PKMKDM4EPOLB | |
| SCHEMBL3123162 | 0.76 | ALDH1A1 (0.41) | ALDH1A1KDM4EHPGDHSD17B10CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8158782-B2 | Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof | WALLAC OY (FI) | 2012-04-17 | — | — | US | disclosed |
| EP-1658282-B1 | NOVEL CHELATING AGENTS AND CHELATES AND THEIR USE | WALLAC OY (FI) | 2010-10-27 | — | — | EP | disclosed |
| US-20090156801-A1 | BIOMOLECULE LABELING REACTANTS BASED ON AZACYCLOALKANES AND CONJUGATES DERIVED THEREOF | NXP B.V. (NL) | 2009-06-18 | — | — | US | disclosed |
| EP-2016060-A1 | BIOMOLECULE LABELING REACTANTS BASED ON AZACYCLOALKANES AND CONJUGATES DERIVED THEREOF | Wallac OY (FI) | 2009-01-21 | — | — | EP | disclosed |
| WO-2007128874-A1 | BIOMOLECULE LABELING REACTANTS BASED ON AZACYCLOALKANES AND CONJUGATES DERIVED THEREOF | WALLAC OY (FI) | 2007-11-15 | — | — | WO | disclosed |
| US-20050084451-A1 | Novel chelating agents and chelates and their use | WALLAC OY | 2005-04-21 | — | — | US | disclosed |
| US-20050054662-A1 | Quinazoline derivatives as antitumor agents | ASTRAZENECA AB (SE) | 2005-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054662-A1 | Quinazoline derivatives as antitumor agents | ERBB2, ERBB3, ABL1 | L3MBTL1 3696/4885ALDH1A1 3334/4885PKM 1894/4885 |
| US-20050084451-A1 | Novel chelating agents and chelates and their use | DNPEP, CNBP, CLTA | L3MBTL1 1735/4885ALDH1A1 4690/4885PKM 4120/4885 |
| US-20090156801-A1 | BIOMOLECULE LABELING REACTANTS BASED ON AZACYCLOALKANES AND CONJUGATES DERIVED THEREOF | DNMT1, PTMS, DNMT3A | L3MBTL1 4285/4885ALDH1A1 405/4885PKM 3656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.